Broad Institute

NOVEMBER 20, 2024

Isselbacher Professor of Medicine at Harvard Medical School, director of the Center for Computational and Integrative Biology and member of the Department of Molecular Biology at MGH, and co-director of the Center for Microbiome Informatics and Therapeutics at MIT.

Regulations 84

Regulations Immune Response Molecular Biology Medical Schools 84

Broad Institute

AUGUST 7, 2023

Now, a team of MIT, Massachusetts General Hospital (MGH), Broad Institute of MIT and Harvard, and Harvard Medical School (HMS) researchers has discovered how STING activates those two pathways. Paper Cited Liu B, Carlson R, et al. Human STING is a proton channel. Online August 3, 2023.

Regulations 91

Regulations Clinical Trials Engineering Science 91

Broad Institute

JUNE 21, 2023

said Vamsi Mootha , senior author of the study, an institute member at the Broad, professor of systems biology and medicine at Harvard Medical School, and professor of molecular biology at Massachusetts General Hospital.

Treatment 98

Treatment Disease Molecular Biology Medical Schools 98

Broad Institute

APRIL 25, 2024

The project is a collaboration between the Broad and the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University outside Lagos in Nigeria, where Happi is a professor of molecular biology and genomics.

Virus 132

Virus Hospitals Disease Government 132

PLOS: DNA Science

AUGUST 22, 2024

Crichton had an MD from Harvard Medical School, but he never practiced medicine. TMV is a common pathogen used in early molecular biology research. Michael_Crichton’s output includes The Andromeda Strain, Jurassic Park, Congo, Twister, The Lost World, Prey, Sphere, Westworld, and the TV series ER.

DNA 67

DNA Virus Organic Chemistry Science 67

Codon

JANUARY 5, 2025

In 1926, one of Cohn’s academic colleagues at Harvard Medical School discovered that patients suffering from pernicious anemia, a form of vitamin B12 deficiency, could be cured by eating liver. Cohn was the only non-medical researcher invited, and he made a big impression. At the time, the U.S.

Laboratories 104

Laboratories Science Production Research 104

Codon

JUNE 26, 2023

Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. … There was a time when the film was being shown in biology courses from middle school to graduate courses in genetics and biochemistry and even in post graduate education lectures to physicians.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JUNE 26, 2023

Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. … There was a time when the film was being shown in biology courses from middle school to graduate courses in genetics and biochemistry and even in post graduate education lectures to physicians.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Broad Institute

JANUARY 30, 2024

He majored in biological chemistry at the University of Chicago and during his junior year, he had a fortuitous meeting with his academic advisor about finding a student research position that would let him dive more deeply into the molecular details of biological systems. A combined MD/PhD program offered both opportunities.

Hospitals 137

Hospitals Virus Medical Schools Science 137

The Pharma Data

OCTOBER 27, 2021

The appointment also builds on other recent Non-Executive Director appointments, including Charles (Charlie) Bancroft, former Executive Vice President at Bristol Myers Squibb (BMS), and Dr Anne Beal, former instructor in paediatrics at Harvard Medical School and Massachusetts General Hospital, and Chief Patient Officer at Sanofi.

Molecular Biology 52

Molecular Biology Science Medical Schools Disease 52

Broad Institute

JANUARY 7, 2025

At the Broad, Rehm wears many hats: chief medical officer for Broad Clinical Labs, a co-leader of Broads Center for Mendelian Genomics , and head of the Translational Genomics Group , a research effort that aims to understand the genetic basis of rare disease.

Disease 121

Disease Science Laboratories Medical Schools 121

Drug Target Review

FEBRUARY 15, 2024

Advances in molecular biology have led to highly safe, efficient, and effective platforms, such as mRNA, that can be rapidly re-purposed for different pathogens, multiple pathogens, or new strains of evolving pathogens. He currently serves as Chief Medical Officer at SIGA Technologies. References Morens D, Fauci A.

Drug Development 122

Drug Development Virus Vaccine Drugs 122